is coupled to a G αq -containing heterotrimeric G protein.
Ras is biochemically activated by phenylephrine and other Post-natal growth of cardiac muscle cells occurs by hypertrophic stimuli (Sadoshima and Izumo, 1993a,b , hypertrophy rather than division and is associated 1996; Thorburn, 1994) . Ras activation is required for with changes in gene expression and muscle fiber phenylephrine-induced hypertrophy and is sufficient to morphology. We show here that the protein kinase induce both morphological and genetic markers of hyper-MEKK1 can induce reporter gene expression from the trophy (Thorburn et al., 1993) . In addition to effects on atrial natriuretic factor (ANF) promoter, a genetic genes that are induced specifically by hypertrophic stimuli, marker that is activated during in vivo hypertrophy.
Ras is also involved in the more general increase in gene MEKK1 induced both stress-activated protein kinase expression that is associated with cardiac muscle cell (SAPK) and extracellular signal-regulated protein kingrowth (Abdellatif et al., 1994) . The Ras effector c-Raf ase (ERK) activity; however, while the SAPK cascade is important in the hypertrophic response since active Raf stimulated ANF expression, activation of the ERK is sufficient to induce hypertrophic gene expression and cascade inhibited expression. C3 transferase, a specific Raf activity is increased by hypertrophic stimuli (Thorburn inhibitor of the small GTPase Rho, also inhibited both et al., 1994a; Bogoyevitch et al., 1995b) . Activation of MEKK-and phenylephrine-induced ANF expression, the Raf-mitogen-activated/extracellular-signal regulated indicating an additional requirement for Rho-dependkinase kinase (MEK)-extracellular-signal regulated (ERK) ent signals. Microinjection or transfection of C3 transprotein kinase cascade also appears to be important in ferase into the same cells did not disrupt actin muscle hypertrophy, although in a more complicated manner. Our fiber morphology, indicating that Rho-dependent pathlaboratory and others have shown that interference with ways do not regulate actin morphology in cardiac ERK activation with catalytically inactive ERK1, the muscle cells. While active MEKK1 was a potent activprotein phosphatase CL100 or antisense oligonucleotides ator of hypertrophic gene expression, this kinase did can inhibit phenylephrine-induced gene expression not induce actin organization and prevented phenyl- (Thorburn et al., 1994b (Thorburn et al., , 1995 Glennon et al., 1996) . ephrine-induced organization. These data suggest that However, conflicting conclusions based on the use of a multiple signals control hypertrophic phenotypes. Posihighly specific MEK inhibitor suggest that the simple tive and negative signals mediated by parallel MAP conclusion that phenylephrine-induced ERK activation is kinase cascades interact with Rho-dependent pathways directly required for expression of genes such as ANF to regulate hypertrophic gene expression while other may be incorrect (Post et al., 1996) . Furthermore, while signals induce muscle fiber morphology in cardiac active Raf or Ras can induce hypertrophic gene expression, muscle cells.
Introduction
associated with the hypertrophic response (Thorburn et al., 1994a,b) although Ras is sufficient to induce these effects. Cardiac muscle cells grow by proliferation during fetal These data suggest that, as in other cells (Joneson et al., development and hypertrophy after birth. Hypertrophic 1996) , different Ras effector molecules may mediate the growth of neonatal cardiac muscle cells is associated with different effects associated with Ras-dependent growth distinct changes in the pattern of gene expression and stimuli. cell morphology. The hypertrophic phenotype can be While hypertrophic growth is a normal developmental monitored by analyzing renewed expression of fetal genes process, cardiac hypertrophy also occurs in adults in such as atrial natriuretic factor (ANF), and cell morphology response to physiological stress such as ischemia/reperfuchanges such as the development of highly organized sion and pressure overload resulting from chronic hypermuscle fibers. In neonatal ventricular myocytes, hypertrophy can be induced by different kinds of stimuli tension. Although initially a compensatory response to the increased cardiac workload resulting from these stimuli, expected. Increased MEKK1 activity also caused increased activation of AP1 from phenylephrine-stimulated cells. continued hypertrophy is associated with cardiac dysfunction and eventual heart failure (Levy et al., 1990) . In vivo, When the ANF promoter was examined ( Figure 1C ), we found that small amounts of the MEKK1-c expression hypertrophic cardiomyopathy may also involve activation of Ras-dependent signaling pathways since transgenic plasmid were sufficient to induce significant luciferase expression. However, larger amounts of the plasmid mice that express constitutively active Ras in their left ventricles display many of the features of this syndrome inhibited expression irrespective of whether or not the cells were stimulated with the bona fide hypertrophic (Hunter et al., 1995) . In ventricular myocytes, several hypertrophic stimuli induce activation of the stressagonist phenylephrine. Maximal MEKK1-c-induced expression was achieved with 100 ng of expression plasmid activated protein (SAP) kinases (also called JNKs) (Bogoyevitch et al., 1995a ) that function in a parallel per transfection reaction, and this level of gene activation was significantly higher than that observed with phenylmitogen-activated protein (MAP) kinase cascade to the ERKs. It seems likely that activation of these kinases and ephrine alone. This amount of MEKK1-c expression plasmid did not produce maximal AP1-driven expression. downstream transcription factors may play a role in the regulation of cardiac hypertrophy as a result of Based on the previous identification of SEK as a preferred substrate over MEK for MEKK (Minden et al., physiological stress. The upstream MAP kinase kinase kinase that plays the equivalent role of Raf in the SAPK 1994; Yan et al., 1994; Cavigelli et al., 1995) , a possible explanation for these results is that small amounts of pathway is thought to be the kinase MEKK1. MEKK1 was identified initially as a kinase capable of activating MEKK1-c were preferentially activating the SEK-SAPK pathway and leading to induction of ANF-driven expres-MEK, the MAP kinase kinase that activates ERK1 and ERK2 (Lange-Carter et al., 1993) . However, MEKK1 is sion. Larger amounts of the MEKK1-c expression plasmid might also activate MEK and ERK, leading to inhibition now thought to be primarily responsible for activation of SEK (also known as JNKK) and the SAPK family of via the mechanisms through which active MEK inhibits expression in phenylephrine-treated cells (Thorburn et al., MAP kinases (Minden et al., 1994; Yan et al., 1994; Derijard et al., 1995 Derijard et al., ). 1995 . To test whether the two families of MAP kinases were activated differentially by different amounts of Since we had suggested previously that activation of the ERK pathway was important in cardiac hypertrophy but MEKK1-c in our experiments, we performed transient transfections with epitope-tagged molecules. Myc-tagged in vivo hypertrophy is often a consequence of physiological stress, we were interested in determining whether activ-ERK2 and HA-tagged SAPKβ were co-transfected along with increasing amounts of MEKK1-c in the same ratios ation of the SAPK pathway by MEKK could affect hypertrophic phenotypes. We find that MEKK1 will induce that were used in the reporter gene expression assays. The tagged molecules were immunoprecipitated and used in hypertrophic gene expression and that this is regulated via both positive and negative signals mediated by the in vitro kinase assays with myelin basic protein (MBP) or GST-Jun as substrates. Figure 1D shows that both SAPK and ERK protein kinase cascades. In addition, Rhodependent signals are required for ANF gene expression.
ERK2 and SAPKβ were activated efficiently even by small amounts of MEKK1-c, and there was no obvious The signals that stimulate hypertrophic gene expression are seperable from those that induce muscle fiber formation. preference for SAPK activation over ERK activation in our cells as has been found in other cell types (see, for example, Cavigelli et al., 1995) . Previously, we reported that active MEK was not able to induce ANF-luciferase expression (Thorburn et al., 1995) ; inactive mutant (D1369A) (Xu et al., 1996) . Figure 1A shows that the wild-type molecule but not the inactive however, other investigators have reported that similar constitutively active MEK molecules can in fact induce mutant activated the ANF promoter in a dose-dependent manner. These data indicate that overexpression of wildhypertrophic gene expression . Since we found that active MEKK1-c was an type MEKK1 is sufficient to induce expression of a gene that is activated during cardiac hypertrophy.
effective activator of the ANF promoter, we designed an experiment to test whether the introduction of active MEK To test the effects of a constitutively active MEKK1 molecule, we co-transfected the reporter plasmid regulated to induce similar amounts of ERK activity resulted in similar amounts of gene expression in cardiac muscle cells. by the ANF promoter with various amounts of an expression plasmid encoding a truncated MEKK1 molecule Figure 2 shows an experiment where various amounts of either an active MEK mutant (ΔN3, S218E, S222D) lacking the putative N-terminal regulatory domain (MEKK1-c) (Xu et al., 1995) . As a control, we transfected (Mansour et al., 1994) or the MEKK1-c expression plasmid were transfected into cardiac cells along with tagged an AP1-luciferase plasmid since AP1 is a known target for the signaling pathways that are activated by MEKK1.
Myc-ERK2 and HA-SAPKβ or AP1-or ANF-luciferase reporters. Figure 2A shows IP kinase assays of the Myc- Figure 1B shows that AP1-driven gene expression is stimulated in a dose-dependent manner by MEKK1-c, ERK2 and HA-SAPKβ molecules, indicating that both MEKK1-c and MEK could efficiently increase ERK confirming that the molecule was active and behaving as activity while, as expected, only MEKK1-c could elevate JNKs are also inactivated by this phosphatase (Gupta et al., 1996) . We found that expression of even small SAPK activity. Figure 2B and C indicates that both MEKK1-c and MEK were efficient inducers of AP1-amounts of CL100 in cardiac muscle cells is effective at inhibiting both SAPKβ and ERK2 that had been activated driven gene expression. Conversely ( Figure 2D and E), only MEKK1-c was able to induce significant ANFby co-transfection of MEKK1-c ( Figure 3A ). Figure 3B indicates that expression of CL100 inhibited MEKK1-cluciferase expression. As before, increasing the amount of MEKK1-c in the transfection mix beyond 100 ng per induced ANF-luciferase expression in a dose-dependent manner. Previously, we found that CL100 inhibited phenylreaction led to repression of ANF-driven gene expression. While it is clear that MEKK1-c was a more effective ephrine-induced ANF-luciferase expression (Thorburn et al., 1995) . These data indicate that ERK, SAPK or ERK activator than MEK, the amount of ERK activity that is stimulated by the small amounts of MEKK1-c activity from both kinases are required for ANF expression.
In an attempt to inhibit the SAPK pathway more expression plasmid that induce maximal ANF-luciferase expression (100 ng) can be achieved by slightly more specifically, we also performed experiments with catalytically inactive versions of SEK and SAPKβ. Figure 3C MEK expression plasmid (500 ng). Thus ERK activation is not sufficient to explain ANF gene expression.
shows that transient transfections with either inactive SEK or an inactive SAPKβ partially inhibit both phenylephrineand MEKK1-c-induced ANF-luciferase expression. The ERK and SAPK differentially regulate MEKK1-c-induced ANF expression extent of inhibition of phenylephrine-induced expression was less than that for MEKK1-c-induced expression. We To test whether activation of the MAP kinases was required for ANF gene expression, we expressed the human phosalso overexpressed a truncated, dominant-negative Jun molecule (ΔNJun) that lacks the trans-activation domain phatase CL100 which dephosphorylates and thus inactivates MAP kinases (Alessi et al., 1993) . The mouse of Jun. This molecule has been shown previously to prevent neuronal cell apoptosis (Ham et al., 1995 ; Xia homolog of CL100 has been reported preferentially to dephosphorylate ERKs rather than SAPKs (Sun et al., et al., 1995) , a phenotype that can be induced by MEKK. Expression of ΔNJun also inhibited MEKK1-c-induced 1994); however, it is clear that various isoforms of SAPK/ ANF-luciferase expression but had little effect on phenylparallel pathways have opposing effects on ANF gene expression, with SAPK-dependent signals leading to ephrine-induced activation of this promoter. Taken together, these results suggest that SAPK and perhaps stimulation of gene expression while MEK-dependent signals cause inhibition. We cannot discriminate between AP1 activation is important for ANF expression.
We also performed experiments to inhibit MEK and inhibitory effects on ANF promoter activity that are mediated by MEK itself or by MEK-induced ERK activity. ERK signaling selectively in the MEKK1-c-transfected cells. In these experiments, we used the MEK-specific inhibitor PD 098059 (Alessi et al., 1995; Dudley et al., C3 transferase inhibits phenylephrine-and MEKK1-c-induced ANF expression 1995). Cells were transfected with the reporter plasmids plus 100 ng of the MEKK1-c expression plasmid and Recently, it has become clear that the small G protein Rho can send signals to the nucleus to activate the treated with increasing amounts of PD 098059 to inhibit MEK activation (Alessi et al., 1995) . Figure 3D shows serum response factor (SRF) and regulate inducible gene expression (Hill et al., 1995) . This activity does not appear that treatment with the MEK inhibitor led to increased ANF-luciferase expression in the MEKK1-c-transfected to involve activation of the currently identified MAP kinases (Hill et al., 1995) , although other Rho family cells. Control kinase assays demonstrated that PD 098059 treatment caused partial but not complete inhibition of GTPases, Rac and Cdc42, can induce SAPK activation Coso et al., 1996) . To test whether MEKK1-c-induced Myc-tagged ERK2 activity without detectably affecting HA-tagged SAPK activity in the same Rho activity was involved in ANF expression, we used the Rho-specific inhibitor C3 transferase. cells (data not shown). Thus while MEKK1 stimulates both MEK-ERK and SEK-SAPK signaling, the two Figure 4A shows that C3 transferase inhibits phenyl- ephrine-induced ANF expression, suggesting that a Rhoinhibitors simultaneously. Figure 4F shows that the two molecules together inhibited expression beyond that dependent signal is required for α-adrenergic agonistinduced gene expression. To test whether Rho was suffiobserved with either molecule alone. These data indicate that the two inhibitory effects are additive, and suggest that cient to induce ANF expression, we performed transfection experiments with a constitutively active molecule at least two separate signals are required for MEKK1-cinduced ANF expression. One signal is inhibited by (V14Rho). Figure 4B shows that this molecule is able to induce only modest ANF-luciferase activity, suggesting inactive SAPKβ and presumably involves SAPK activation, the other signal is inhibited by C3 transferase and that while Rho may be required for expression, it is not sufficient for efficient expression from this promoter. We is therefore Rho dependent. IP kinase assays indicated that expression of C3 transferase had no significant effect did not observe inhibition of phenylephrine-stimulated AP1 activity by C3 transferase ( Figure 4C) . on MEKK1-c-induced ERK2 or SAPKβ activity (data not shown), further supporting the view that MAP kinaseTo determine whether Rho activity was also required for MEKK1-c-induced gene expression, we performed dependent and Rho-dependent signals that regulate ANF expression are separate. transfection experiments expressing C3 transferase plus MEKK1-c. Figure 4D shows that C3 transferase partially inhibited MEKK1-c-induced ANF expression. In parallel C3 transferase does not inhibit actin organization in cardiac muscle cells transfections, this amount of C3 transferase completely abolished phenylephrine-induced ANF expression. As Neonatal cardiac muscle cell hypertrophy is associated with obvious morphological changes. The cells increase before, C3 transferase did not inhibit AP1 activity ( Figure  4E ) induced by either phenylephrine or MEKK1-c.
in area, become more regularly shaped and develop highly organized muscle fibers as shown by staining to reveal Since we found that both catalytically inactive SAPKβ and C3 transferase partially inhibited MEKK1-c-induced filamentous actin. Figure 5A shows the pattern of actin staining found in unstimulated cells, while
Figure 5B ANF expression, we performed experiments using both shows the highly organized pattern that is induced by a expression, we also determined whether C3 transferase affected hypertrophic cell morphology. Recombinant C3 24 h treatment with phenylephrine. Previously we showed that these morphological changes can be induced by Ras transferase protein plus a marker IgG molecule was microinjected into cardiac muscle cells that were then (Thorburn et al., 1993) but do not appear to involve ERK or Raf signaling (Thorburn et al., 1994a,b) . Rho is known treated with phenylephrine to induce hypertrophy. Surprisingly, injection of C3 transferase plus IgG ( Figure 5C ) to be a key regulator of actin morphology in other cell types (Ridley and Hall, 1992) . Since inhibition of Rho by had no effect on actin organization in response to phenylephrine ( Figure 5D ). As expected, control injections of C3 transferase had a clear effect on hypertrophic gene IgG alone had no effect on actin morphology (data not using 3 μg of the expression plasmid in each transfection mix, i.e. the same amount of C3 expression plasmid that shown). As a control to ensure that the C3 protein was led to complete inhibition of ANF-luciferase ( Figure 4A ). active, we performed injection experiments in serum- Figure 6F shows the same field stained with phalloidin, starved NIH 3T3 cells then treated these cells with 10% indicating again that C3 transferase does not prevent actin fetal calf serum. Injected fibroblasts rounded up within an organization into muscle fibers. When C3 transferasehour and displayed a significantly altered morphology containing cells were counted and scored for actin organindicating that the C3 transferase protein was active (data ization into muscle fibers, we found that~90% of the not shown). cells showed clear actin organization after phenylephrine One possible explanation for the lack of effect of treatment. To exclude the possibility that timing was recombinant C3 protein on the heart cells was that we did affecting the outcome of these experiments, we fixed cells not achieve a high enough amount of C3 protein in the either at 24 or 48 h (i.e. when cells were harvested for cell to produce an inhibitory effect in our relatively longluciferase assays) after transfection. At both times, the term assay for actin morphology. We therefore repeated transfected cardiac muscle cells, identified by GFP the morphology experiments using microinjected or transfluorescence, had highly organized actin and were, in fact, fected C3 expression plasmids. Figure 6 shows the results contracting rhythmically before fixation. In further control obtained. Cells that contained the C3 expression plasmids experiments, we found that injected or transfected C3 were identified by co-injection or co-transfection of a transferase expression plasmids prevented luciferase green fluorescent protein (GFP) expression plasmid. Figure  expression from the ANF-luciferase reporter that was 6A shows GFP fluorescence in control cells, indicating monitored by immunofluorescence staining with antithat injection of plasmids did not affect phenylephrineluciferase antibodies (data not shown). When C3 expresinduced morphology ( Figure 6B) . Figure 6C and D shows sion plasmids were injected into NIH 3T3 or REF52 cells, cells injected with the C3 expression plasmid plus the the injected cells displayed marked morphological changes GFP plasmid, again indicating that C3 expression did not and, after 2-3 h, were rounded, had severely disrupted prevent actin organization. To exclude the possibility that actin stress fibers and were poorly attached to the dish, injected plasmids were not as effective as transiently further indicating that the expression plasmid was active. transfected C3 plasmids (which we know to be active in heart cells since they abolish phenylephrine-induced ANF-MEKK1-c does not induce morphological luciferase expression, Figure 4A ), we also monitored actin phenotypes associated with hypertrophy morphology in transiently transfected cells. Figure 6E We also tested whether active MEKK was able to induce the morphological phenotypes associated with cardiac shows GFP fluorescence from transiently transfected cells hypertrophy. For these experiments, the MEKK1-c expresmuscle cells, e.g. the cell between the two transfected cells on the right hand side of the field, had organized sion plasmid was transfected into cells along with the GFP expression plasmid. Cells were monitored for GFP muscle fibers. Control cells ( Figure 8A and B) showed no disruption. Similar inhibition was observed whether fluorescence to identify transfected cells and stained for actin organization. Figure 7A and B shows control cells small (100 ng) or large amounts (3 μg) of the MEKK1-c expression plasmid were used in the transfection mix or that were transfected with the GFP expression plasmid and empty vector, indicating that transfection alone does whether cells were injected or transfected. Unlike the C3 transferase-containing cells, MEKK1-c-containing cells not induce muscle organization. Figure 7C and D shows cells expressing small amounts of MEKK1-c (100 ng of when identified by GFP fluorescence before fixation did not contract even when the dish was treated with phenylexpression plasmid per transfection mix, the amount that caused maximal ANF-luciferase expression); these cells ephrine and neighboring cells were capable of contraction, further indicating that expression of MEKK1-c prevents did not display morphological phenotypes associated with hypertrophy. Figure 7E and F shows cells that were functional muscle fiber formation. transfected with 100 ng of the MEKK1-c expression plasmid then treated with the MEK inhibitor PD 098059; Discussion these cells also did not show any organization into muscle fibers. Thus the conditions that lead to maximal MEKK1-In this study, we have shown that MEKK1 can cause expression of a marker gene, ANF, that is induced by driven ANF-luciferase expression were not sufficient to induce the morphological phenotypes associated with hypertrophic stimuli in cardiac muscle cells. In our cells, MEKK1 appears to be almost equally good at activating hypertrophy. Figure 8 shows the results obtained when MEKK1-c the ERK and SAPK pathways, unlike the situation in other cell types where MEKK1 preferentially activates the was expressed in phenylephrine-treated cells. Surprisingly, expression of MEKK1-c inhibited actin organization into SAPK pathway (Minden et al., 1994; Yan et al., 1994) . Thus there may be cell type-specific differences in the muscle fibers in response to phenylephrine treatment ( Figure 8C and D) , although surrounding untransfected effects of introduction of these various upstream kinases and it may not be possible to extrapolate from one cell MEKK could induce ANF expression (Bogoyevitch et al., 1996) . SAPKs are also activated by ischemia/reperfusion type to another.
We found that small amounts of constitutively active of kidney cells (Pombo et al., 1994) . The experiments showing that transient transfection of MEKK1 were strong activators of ANF-luciferase expression while larger amounts of MEKK1-c led to inhibition C3 transferase expression plasmids inhibits both phenylephrine-and MEKK1-c-induced ANF expression indicate both in the absence and presence of phenylephrine. The experiments shown in Figure 2 indicate that activation of that hypertrophic gene expression also requires Rhodependent signals. Interestingly, while relatively large either high or low levels of ERK activity are not sufficient to explain ANF induction. Expression of catalytically amounts of C3 transferase (3 μg per transfection) completely abolished phenylephrine-induced ANF expression, inactive SEK or SAPK mutants inhibits MEKK1-cinduced ANF expression while inhibition of MEK by this amount of the inhibitor only partially inhibited MEKK1-c-induced expression. The simplest explanation treatment with PD 098059 caused further stimulation of ANF promoter-driven gene expression. Thus the level of of these results is that at least two separate signals regulate ANF expression. One signal is dependent upon SAPK MEKK1-induced ANF-luciferase expression is the product of positive signals mediated via the SEK-SAPK pathway activation while the other signal is Rho-dependent. While both signals seem to have a role to play, the relative and inhibitory signals mediated via MEK. Since MEKK1-c appears to induce hypertrophic gene expression in part importance of these signals may be different for phenylephrine-and MEKK1-induced ANF expression. This idea via the SAPKs, these results may be relevant for the understanding of hypertrophic gene expression during is supported by the observation that inactive SEK or SAPK is a fairly effective inhibitor of MEKK-induced clinically important cellular stresses, such as cardiac ischemia or pressure overload, that are likely to cause ANF expression but a poor inhibitor of phenylphrineinduced expression, while C3 transferase is a more effect-SAPK activation. In this respect, it was reported recently that ischemia/reperfusion stimulates SAPK activation in ive inhibitor of phenylephrine-induced than MEKKinduced expression. We have not been able to demonstrate heart muscle. These authors also showed that active inhibition of phenylephrine-induced ANF expression by found that neither dominant-negative Rho nor Rac had any effect on muscle organization; however, dominantcatalytically inactive MEKK1; this result is consistent with the idea that there may be functional differences negative Ras-transfected or injected cells sometimes showed disorganized muscle fibers as did occasional between the mechanism of activation of this promoter by these two stimuli. A likely Rho-dependent target for ANF dominant-negative Cdc42-transfected cells. However, when we counted the transfected cells and scored them gene expression is the SRF whose activity is known to be dependent upon Rho in fibroblasts (Hill et al., 1995) .
as organized or disorganized, the number of organized cells after transfection with these mutants was not statistically An SRF-like activity is important for both basal and phenylephrine-stimulated ANF expression in cardiac different from controls (data not shown). This result suggests that there may be a requirement for Ras-and muscle cells (Sprenkle et al., 1995) , and SRF has been implicated in hypertrophic stimulation of the skeletal also perhaps Cdc42-dependent signals in muscle organization but that it will be difficult to characterize further the α-actin gene Karns et al., 1995) .
Rho-dependent pathways regulate actin morphology by mechanisms responsible using these approaches. Active Ras can induce hypertrophic morphology (Thorburn et al. , inducing the formation of actin stress fibers and focal adhesions in fibroblasts (Ridley and Hall, 1992, 1994; ; however, we have been unable to demonstrate induction of actin organization in cells injected or transNobes and Hall, 1995). We therefore suspected that interference with Rho-dependent signaling might prevent fected with activated mutants of Cdc42, Rac or Rho. MEKK1-c was an effective inhibitor of actin organizthe organization of filamentous actin into muscle fibers. Since C3 transferase had no effect on phenylephrineation. In contrast to the experiments with the dominantnegative G proteins, almost every MEKK1-c-transfected induced actin organization while it did inhibit gene expression, we conclude that Rho-dependent signals do not cell had disrupted muscle fibers. This result shows that it is possible to disrupt muscle fiber formation in the transfecregulate actin organization into muscle fibers. These data do not exclude a possible role for Rho in muscle organiztion assays, indicating that the failure to do so with a molecule such as C3 transferase is not simply because it ation that is induced by other stimuli. We also performed experiments to test whether dominant-negative Ras, Rac, is impossible to inhibit organization in response to a strong hypertrophic stimulus such as phenylephrine. Active Cdc42 or Rho could inhibit muscle fiber formation. We subcloned into an EF-driven plasmid into which the HA tag sequence MEKK1-c was not sufficient to induce hypertrophic mor- (Russell et al., 1995) In conclusion, the data presented here indicate that Gene expression and kinase assays multiple signaling pathways regulate cardiac gene expresTransient transfections were performed in triplicate by calcium phossion during hypertrophic growth. Activation of gene phate-mediated transfection as previously described (Thorburn et al., expression occurs as a result of signals that are dependent 1993, 1994a,b, 1995) effects on gene expression, for example by activating Transfection efficiencies were normalized by dividing the luciferase ternary complex factors such as Elk1 (Gille et al., 1995;  activity from each dish by the β-galactosidase activity from the same Whitmarsh et al., 1995) . Differential effects of these two dish. Data in each experiment are presented as the mean Ϯ SD of MAP kinase cascades can account for survival versus triplicates from a representative experiment. All experiments were performed at least three times with different preparations of plasmids apoptosis of PC12 cells (Xia et al., 1995) , but in this case and primary cells, producing qualitatively similar results.
it is not clear what the target genes responsible for this
Epitope-tagged kinase assays were performed as before (Thorburn differential effect might be. Since the ANF promoter is et al., 1994a, 1995) . In all cases, both Myc-tagged ERK2 and HAregulated both positively and negatively by these pathways, tagged SAPKβ were co-transfected with expression vectors for the this experimental system may provide a useful opportunity various kinases or CL100 to be tested, then the cell lysate was split for separate immunoprecipitations using the 9E10 (Myc) or 12CA5 (HA) to characterize mechanisms of differential effects of paralmonoclonal antibodies and finally used in kinase assays with MBP lel MAP kinase cascades. We currently are analyzing the (Sigma, St Louis, MO) or GST-Jun (1-169) as substrates respectively. ANF promoter to identify further the DNA elements and transcription factors that might mediate these differential Cell morphology assays effects. The regulation of actin into muscle fibers in Cells for morphological analysis were plated on chamberslides. Microinjection experiments were performed as previously described in the response to hypertrophic stimuli does not involve these presence of 20 mM 2,3 butanedione monoxime (Sigma) to prevent signaling pathways, although it can be inhibited by active excessive contraction as a result of calcium influx (Thorburn et al., MEKK1. Future studies using MEKK1-mediated inhibi-1993). Recombinant C3 protein was produced as a GST fusion protein, tion of actin organization should provide a way to characcleaved with thrombin and injected at a needle concentration of 1 mg/ml along with 4 mg/ml rat IgG to identify injected cells; control injections terize further the molecular mechanisms that regulate contained rat IgG alone. One hour after injection, phenylephrine was muscle organization.
added to the media. Cells were fixed 24 h later and stained with FITCconjugated anti-Rat to identify injected cells and rhodamine-phalloidin (Sigma) to show filamentous actin. For studies with expression plasmids,
Materials and methods
injections were performed with a GFP expression plasmid pGreenLantern (BRL, Gaithersburg, MD) to identify cells. The C3 transferase expression Cell culture plasmid or MEKK1-c expression plasmid and the GFP plasmid were Primary ventricular cardiac myocytes were isolated from 1-day-old rats injected at a concentration of 0.5 mg/ml each in the needle. Cells were by collagenase digestion and maintained in Dulbecco's modified Eagle's maintained in serum-free media for 1 h to allow expression (Alberts medium (DMEM)/medium 199 (4/1) supplemented with penicillin and et al., 1993) , then treated with phenylephrine for 24 h before fixation streptomyocin. For transfection experiments, cells were plated at a and staining with rhodamine-phalloidin. Injected cells were identified density of 2.5ϫ10 5 per 3.5 cm dish (for gene expression assays) or by virtue of their GFP fluorescence. Transient transfections were also 7.5ϫ10 5 per 6 cm dish (for epitope-tagged kinase assays). For morphoperformed with these plasmids. For transient transfection experiments, logy experiments, cells were plated on chamber slides at the same density.
cells were fixed at both 24 and 48 h after phenylephrine treatment with identical results. Control injections in NIH 3T3 and REF52 cells were Plasmids performed in cells that had been starved in 0.1% serum-containing media Expression plasmids for full-length wild-type or catalytically inactive for 24 h prior to injection, then treated with 10% fetal bovine serum (D1369A) MEKK1 and truncated MEKK1-c consisting of only the after injection. catalytic domain were constructed in cytomegalovirus (CMV)-driven plasmids (Xu et al., 1995 (Xu et al., , 1996 . The expression plasmid for Myctagged ERK2 was constructed by subcloning the ERK2 cDNA into an
